Clinical Trial Update: Comparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial comparing de-escalated surgery to standard surgery after neoadjuvant immunotherapy in locally advanced head and neck squamous cell carcinoma is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Qunxing Li,MD | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | NA | Status: RECRUITING